Works matching AU Pottegård, Anton


Results: 274
    1

    Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma.

    Published in:
    2016
    By:
    • Pottegård, Anton;
    • Schmidt, Sigrún Alba Johannesdottir;
    • Olesen, Anne Braae;
    • Achacoso, Ninah;
    • Van Den Eeden, Stephen K;
    • Hallas, Jesper;
    • Sørensen, Henrik Toft;
    • Friis, Søren;
    • Habel, Laurel A;
    • Pottegård, Anton;
    • Schmidt, Sigrún Alba Johannesdottir;
    • Sørensen, Henrik Toft;
    • Friis, Søren
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real‐world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2023, v. 32, n. 1, p. 44, doi. 10.1002/pds.5507
    By:
    • Wang, Shirley V.;
    • Pottegård, Anton;
    • Crown, William;
    • Arlett, Peter;
    • Ashcroft, Darren M.;
    • Benchimol, Eric I.;
    • Berger, Marc L.;
    • Crane, Gracy;
    • Goettsch, Wim;
    • Hua, Wei;
    • Kabadi, Shaum;
    • Kern, David M.;
    • Kurz, Xavier;
    • Langan, Sinead;
    • Nonaka, Takahiro;
    • Orsini, Lucinda;
    • Perez‐Gutthann, Susana;
    • Pinheiro, Simone;
    • Pratt, Nicole;
    • Schneeweiss, Sebastian
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22

    Hydrochlorothiazide and risk of melanoma subtypes.

    Published in:
    Pharmacoepidemiology & Drug Safety, 2021, v. 30, n. 10, p. 1396, doi. 10.1002/pds.5266
    By:
    • Habel, Laurel A.;
    • Achacoso, Ninah;
    • Fireman, Bruce;
    • Pedersen, Sidsel Arnspang;
    • Pottegård, Anton
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    Ischemic Stroke and Systemic Embolism in Warfarin Users With Atrial Fibrillation or Heart Valve Replacement Exposed to Dicloxacillin or Flucloxacillin.

    Published in:
    Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 3, p. 607, doi. 10.1002/cpt.1662
    By:
    • Hellfritzsch, Maja;
    • Lund, Lars Christian;
    • Ennis, Zandra;
    • Stage, Tore;
    • Damkier, Per;
    • Bliddal, Mette;
    • Jensen, Peter Bjødstrup;
    • Henriksen, Daniel;
    • Ernst, Martin Thomsen;
    • Olesen, Morten;
    • Broe, Anne;
    • Kristensen, Kasper Bruun;
    • Hallas, Jesper;
    • Pottegård, Anton
    Publication type:
    Article
    46
    47
    48
    49
    50